skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Terrible markets with NQ in bear space. NVTA,PATH, PLTR,BL are at/near new lows. Reportedly PLTR reports before open,May 9. All in Investment a/c.,except BL in Tfsa. Thinking of selling at a loss before they get worse,which maybe offset by potential capital gain of other stocks at a later date. Appreciate u short view on each. Txs for u usual great views & services.
Read Answer Asked by Peter on May 10, 2022
Q: Hi 5i,

I was looking forward to the US part of the answer to Aleem’s recent question.

Specifically, can I get your two top US picks for each of consumer cyclical, consumer defensive and industrials based on current valuation and long-term growth.

Thanks as always,

Kevin
Read Answer Asked by Kevin on May 10, 2022
Q: For the companies listed, do you believe any are at risk of fully going out of business with respect to the current market and recent/anticipated stock pricing effecting their ability to continue to operate? thanks!
Read Answer Asked by Andrew on May 10, 2022
Q: In one of your responses you stated "But, there are good signs, such as 20% of biotech companies in the US now trading below cash levels". If this is net cash (i.e. after debt), wouldn't these be great buying opportunities, assuming the companies are solid. They would eventually trade at their cash position (at minimum, I would have to believe). If my thesis is correct, can you name a few of these companies. I think this may be pretty much a sure thing?
Read Answer Asked by Walter on May 10, 2022
Q: Are these stocks still expensive? In what order would you buy them today?

Thank you for great service.
Milan
Read Answer Asked by Milan on May 10, 2022
Q: These two companies are incredibly innovative and have developed the vaccines that save us all. They are very profitable with Moderna selling at a PE of 5 and BioNtech at a PE of 3.2. Yet they continue to go down. They also have quite a few medicines in their pipelines. I have 65 shares of MRNA in my TFSA. Your thoughts?
Read Answer Asked by Ross on May 09, 2022
Q: Please comment on Mgni's Q1 results released on May 4,& guidance. Apparently Rev & Eps beat estimates. On May 5 it closed at $10.94 + 0.32 despite great Bear attack on the markets.On may 6 dropped $1.07 to $9.87.Any reasons. Txs for u usual great services & views.May have asked similiar Q earlier
Read Answer Asked by Peter on May 09, 2022
Q: I am down about 30% with Keysight. I am thinking of selling it to harvest the loss and purchasing Qualcomm in place.

QCOM is much bigger and has a noticeably lower P/E (14.87 v. 27.10) somewhat better Price to Cash Flow (17.9 v. 21.3);

But QCOM has a higher P/B (12.18 v. 6.87) and while not worrisome, a noticeably higher Debt / Equity ratio( 1.8 v. 0.53).

Which matrix would you use to evaluate these 2 companies?

Which of the 2 do you see having a better prospect going forward?

Thank you for your excellent service.
Read Answer Asked by Leonard on May 06, 2022
Q: The above stocks have declined significantly from 2021 highs. I would like to make 2 or 3 purchases from this list. Please remove any you think are unlikely to resume upwards momentum over next 12 months and show the rest in a priority list for purchase consideration from highest priority to lowest for growth or growth/dividend return. Many thanks. Jane Norton
Read Answer Asked by Jane on May 06, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!